Colorectal cancer, the abnormal growth of cancerous cells in the large intestine or the rectum, is one of the most common ...

Results from a groundbreaking clinical trial could soon change the way certain types of cancers are treated. A study published Sunday in the New England Journal of Medicine found that immunotherapy ...

A new treatment for rectal cancer is allowing some patients to avoid surgery. Doctors are seeing more young adults diagnosed ...

Intermountain Health is the first in the nation to use a new tool using a 3D computer model for rectal cancer surgery. The new technology, called Iris, guides surgeons during robotic rectal cancer ...

Dostarlimab treatment led to complete clinical responses in 82% of patients with dMMR tumors, avoiding surgery for most. Recurrence-free survival at two years was 92%, with a median follow-up of 20 ...

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the ...